North America Insomnia Therapeutics Market Size & Outlook
Related Markets
North America insomnia therapeutics market highlights
- The North America insomnia therapeutics market generated a revenue of USD 1,024.4 million in 2024.
- The market is expected to grow at a CAGR of 4% from 2025 to 2030.
- In terms of segment, benzodiazepines was the largest revenue generating type in 2024.
- Benzodiazepines is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 1,024.4 million |
| Market revenue in 2030 | USD 1,292.7 million |
| Growth rate | 4% (CAGR from 2025 to 2030) |
| Largest segment | Benzodiazepines |
| Fastest growing segment | Benzodiazepines |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists |
| Key market players worldwide | Takeda Pharmaceutical Co Ltd, Vanda Pharmaceuticals, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Sumitomo Pharma Co Ltd, Sanofi SA, Paratek Pharmaceuticals, Ebb Therapeutics |
Other key industry trends
- In terms of revenue, North America region accounted for 35.4% of the global insomnia therapeutics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 957.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insomnia Therapeutics Market Scope
Insomnia Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ebb Therapeutics | View profile | 1-10 | Pittsburgh, Pennsylvania, United States, North America | https://ebbsleep.com/ |
| Vanda Pharmaceuticals | View profile | 251-500 | Washington, District of Columbia, United States, North America | http://www.vandapharma.com |
| Mylan N.V. | View profile | - | - | - |
| Sumitomo Pharma Co Ltd | View profile | 6250 | 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Japan, 541-0045 | https://www.sumitomo-pharma.com |
| Paratek Pharmaceuticals | View profile | 251-500 | Boston, Massachusetts, United States, North America | http://paratekpharma.com/ |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
North America insomnia therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insomnia therapeutics market will help companies and investors design strategic landscapes.
Benzodiazepines was the largest segment with a revenue share of 30.34% in 2024. Horizon Databook has segmented the North America insomnia therapeutics market based on benzodiazepines, nonbenzodiazepines, antidepressants, orexin antagonists, melatonin antagonists covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America insomnia therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America insomnia therapeutics market databook
-
Our clientele includes a mix of insomnia therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America insomnia therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into North America insomnia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America insomnia therapeutics market size, by country, 2018-2030 (US$M)
North America Insomnia Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
